What blood tests are used to monitor Breast Cancer
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Blood Tests for Monitoring Breast Cancer
Blood tests play an important role in breast cancer care. They help your care team assess your overall health, monitor how well your organs are functioning, and in some cases, track how your cancer is responding to treatment. Let me walk you through the main blood tests you might encounter.
Standard Blood Tests
According to NCCN Guidelines for Patients: Invasive Breast Cancer, several routine blood tests are commonly used:
Complete Blood Count (CBC)
This test measures three key components of your blood:
- Red blood cells (RBCs) – carry oxygen throughout your body
- White blood cells (WBCs) – fight infection and support your immune system
- Platelets (PLTs) – help control bleeding
During cancer treatment, these levels can drop, so your care team monitors them regularly to ensure your body is tolerating treatment well.
Comprehensive Metabolic Panel (CMP)
This test checks 14 different substances in your blood and provides crucial information about:
- Kidney function – how well your kidneys are filtering waste
- Liver function – how well your liver is processing nutrients and removing toxins
- Other organ health – electrolytes and other important chemicals
This is especially important because some breast cancer treatments can affect kidney and liver function.
Liver Function Tests (LFTs)
These tests specifically measure chemicals made or processed by your liver. According to the NCCN Guidelines, abnormal LFT results can signal either that your liver isn't working optimally OR that cancer may have spread to the liver. It's also common to see mild increases in LFTs during chemotherapy, which your doctor will monitor.
Alkaline Phosphatase (ALP)
This is an enzyme found in your blood. High levels of ALP can be a sign that cancer has spread to the bone or liver. If your ALP is elevated, your care team may recommend additional imaging tests like a bone scan to investigate further.
Tumor Markers
According to NCCN Guidelines for Patients: Invasive Breast Cancer, blood tests may also check for tumor markers – proteins that can indicate cancer activity. Examples include:
- CEA (carcinoembryonic antigen)
- CA 15-3
- CA 27.29
Important context: An increase in tumor marker levels may suggest that cancer has grown or spread. However, not everyone with breast cancer has elevated tumor markers, and tumor markers alone are not reliable for detecting breast cancer. Your doctor will use them as one piece of information alongside imaging and other tests.
Biomarker Testing from Blood
For patients with metastatic (advanced) breast cancer, NCCN Guidelines mention that blood samples can be tested for:
- Circulating tumor DNA (ctDNA) – pieces of DNA from tumor cells floating in your bloodstream
- Specific mutations – genetic changes that might respond to targeted therapies
This type of "liquid biopsy" can be particularly useful because it's less invasive than tissue biopsies and can be repeated over time to monitor how your cancer is changing.
How Often Are These Tests Done?
The frequency depends on your specific situation:
- During active treatment – typically every few weeks
- After treatment – less frequently, as determined by your care team
- If monitoring for recurrence – based on your individual risk factors and symptoms
Questions to Ask Your Care Team
To better understand your blood test results:
- "What do my specific blood test results mean for my treatment plan?"
- "Are there any results that concern you, and what does that mean?"
- "How often will we be checking these tests, and why?"
- "If any values are abnormal, what's the next step?"
- "Are there any tumor markers you're specifically tracking for me, and why?"
Key Takeaway
Blood tests are a routine part of breast cancer monitoring. They help your care team understand how your body is responding to treatment and whether your cancer is responding as expected. While these tests provide valuable information, they're always interpreted in the context of your complete clinical picture – including imaging, physical exams, and how you're feeling.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Invasive Breast Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with prognosis for Breast Cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
Im interested in integrative options to pysh cancer back in remission. No need tO Rely of NCCN, use data from...
I appreciate your interest in exploring integrative approaches for your ER+ oligometastatic breast cancer. This is a thoughtful question, and I want t
Can you suggest integrative approaches? Possibly i can stop the progression. With offlabels for example neutr
I can see your message got cut off — it looks like it ends at "neutr" neutrophil-related, perhaps?. Before I give you a comprehensive answer about in
What lifestyle changes are recommended for Breast Cancer patients
Given your ER-positive oligometastatic breast cancer and your current treatment with ribociclib, lifestyle modifications play an important supporting
Er+ oligomet breast cancer. Have been 5aking ribocyclib for 14 months. Because of my low neutrophils the dose was...
I want to make sure I'm giving you the most helpful educational information. Let me clarify what I'm seeing in your message — it looks like it got cut
How do I find the best clinical trial for breast cancer
Clinical trials can be an important option to explore as part of your breast cancer treatment plan. Here's how to approach finding one that might be r